Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS)

10.49 +0.09 (+0.87%) At close: 03:00PM CST

Zhejiang Ausun Pharmaceutical Co., Ltd.

No. 5 Donghai Fourth Lane
Linhai Park Zhejiang Chemical API Base
Linhai 317016
China
86 576 8558 9335
https://www.ausunpharm.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Zhiguo Zheng	Chairman & GM	N/A	N/A	1971
Mr. Huadong Zhang	Deputy GM & Director	N/A	N/A	1977
Mr. Xiaochen Ying	Board Secretary	N/A	N/A	1981

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Zhejiang Ausun Pharmaceutical Co., Ltd. engages in the research and development, process development, manufacture, and sale of APIs and pharmaceutical intermediates. It offers fluorine products, prostaglandins, antimicrobials, and oncology products. The company also provides products for liver disease, respiratory system, and cardiac and cerebral vessels, as well as CNS indications. In addition, it offers development and manufacturing services to the pharmaceutical, cosmetics, and nutritional industries. The company was founded in 2010 and is based in Linhai, China.

Corporate governance

Zhejiang Ausun Pharmaceutical Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.